
Zolnap 6.25mg Tablet XR
Marketer
Icon Life Sciences
Salt Composition
Zolpidem (6.25mg)
Overview Zolnap 6.25mg Tablet XR
SomniRest 6.25mg Extended-Release Tablets are indicated for the short-term management of sleeplessness. They shorten the time it takes to fall asleep and lessen nighttime awakenings, promoting sustained sleep. SomniRest 6.25mg Extended-Release Tablets should be administered on an empty stomach, ideally just before bedtime. Consistent daily timing is recommended for maintaining stable drug levels. Always follow your physician's prescribed dosage and duration, as this medication can be habit-forming; never discontinue use abruptly without consulting your doctor, as this may exacerbate your symptoms. Potential side effects, some occurring temporarily and resolving spontaneously, include amnesia, visual disturbances, restlessness, cephalalgia, dizziness, bowel irregularities, nausea, emesis, and back discomfort. Fatigue, abdominal pain, diplopia, and depressive symptoms are also possible. Report any persistent or bothersome side effects to your doctor. SomniRest 6.25mg Extended-Release Tablets may induce drowsiness and vertigo; avoid driving or activities demanding concentration until their effects are known. Refrain from alcohol consumption while using this medication as it may increase dizziness. Report any unusual mood shifts, new or worsening depression, hallucinations, or suicidal ideation to your physician immediately. Prior to initiating SomniRest 6.25mg Extended-Release Tablets, disclose all other medications to your doctor to ensure safe use. Individuals with hepatic or renal impairment should consult their physician before use. Smoking and alcohol should be avoided while taking this medicine. This medication is contraindicated during pregnancy and lactation; consult your doctor if use becomes necessary.
Primary Ingredients of Zolnap 6.25mg Tablet XR
No text was provided to rewrite.
Uses of Zolnap 6.25mg Tablet XR
Managing Sleep Difficulties
Major Benefits of Zolnap 6.25mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Zolnap 6.25mg Tablet XR whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Zolnap 6.25mg Tablet XR:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Zolnap 6.25mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 6.25mg Zolnap XR tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Zolnap 6.25mg Tablet XR works:
Extended-release Zolnap 6.25mg tablets are classified as non-benzodiazepine sleep aids. Their mechanism involves modulating the GABAA receptor chloride channel complex, a key neurotransmitter, to reduce neuronal excitability in the brain, thereby promoting sleep. These tablets exhibit hypnotic, sedative, and anticonvulsant effects, helping to control seizures.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Zolnap 6.25mg extended-release tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Zolnap 6.25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Zolnap 6.25mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Zolnap 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Zolnap 6.25mg tablets are considered safe for individuals with kidney impairment; dosage modification is not typically necessary. Nevertheless, disclosure of any kidney condition to your physician is advised.
LiverCAUTION
Patients with liver impairment should use Zolnap 6.25mg XR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Zolnap 6.25mg Tablet XR :
Omit any missed Zolnap 6.25mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zolnap 6.25mg Tablet XR
| Label | Value |
|---|---|
| Chemical Category | Imidazopyridine compound |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Non-benzodiazepine sleeping pills (Z-drugs) |
